Previous 10 | Next 10 |
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2023 results after the financial markets close on Wednesday, February 21, 2024. The Company will hold a conference call and simultaneous webcast...
2024-01-12 00:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Abbott’s latest innovation, the FreeStyle Libre ® 2 Plus sensor, is available for the first time for t:slim X2 ™ insulin pump users in the U.S. Tandem’s Control-IQ ™ hybrid closed-loop technology now integrates with the first and only 15-day contin...
2023-12-28 03:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the launch of Tandem Source, a diabetes management platform for insulin pump users and healthcare providers (HCPs). Tandem Source is designed to bring together the features of Ta...
2023-12-12 11:07:43 ET Summary Investors should consider tax-loss selling before December ends to offset capital gains. Two characteristics to consider for selling stocks are stocks bought at a higher price and broken companies with weak long-term prospects. Stock grades, sent...
– First Automated Insulin Delivery System in the World to Feature Dexcom’s Most Advanced CGM Technology – Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the launch of updated t:slim X2™ i...
2023-11-17 09:20:22 ET Summary Medtronic plc will announce its fiscal year 2024 Q2 earnings Tuesday 21st November. Analysts expect Q2 revenues of ~$7.9bn, normalized EPS of $1.18, and GAAP EPS of $0.81. Key areas of focus include the impact of U.S.-China relations, supply chai...
2023-11-17 08:45:44 ET Palm Beach, FL – November 17, 2023 – FinancialNewsMedia.com News Commentary – The global diabetes therapy and treatment market is driven primarily by increased diabetes prevalence, sedentary lifestyles, and most other chronic diseases,...
2023-11-06 06:26:33 ET Summary Today, we take a look at Tandem Diabetes Care, whose shares have declined by 65% due to the belief new weight loss drugs will reduce the demand for insulin injections. The company develops and commercializes products for people with insulin-dependent...
News, Short Squeeze, Breakout and More Instantly...
Tandem Diabetes Care Inc. Company Name:
TNDM Stock Symbol:
NASDAQ Market:
Tandem Diabetes Care Inc. Website:
U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining more than 1% on Friday. The Dow traded up 1.27% to 38,712.21 whil...
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining 2% on Friday. The Dow traded up 1.16% to 38,670.87 while the NA...
2024-05-03 16:34:00 ET Tandem Diabetes Care (NASDAQ: TNDM) stock exploded higher after reporting a sales beat Thursday evening. Analysts forecast the maker of t:slim X2 insulin pumps would lose $0.76 per share on sales of $174 million in 2024's first quarter. Tandem did lose mon...